ArticleCurrent oncology (Toronto, Ont.)2022

Long-Term Toxicities of Immune Checkpoint Inhibitor (ICI) in Melanoma Patients.

Justin Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.